[{"orgOrder":0,"company":"Chia Tai Tianqing Pharmaceutical Group","sponsor":"Inapplicable","pharmaFlowCategory":"DU","therapeuticArea":"Hematology","country":"CHINA","productType":"Undisclosed","year":"2025","type":"Inapplicable","leadProduct":"Undisclosed","moa":"Undisclosed","graph1":"Hematology","graph2":"Undisclosed","graph3":"Chia Tai Tianqing Pharmaceutical Group","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Hematology","amount2New":0,"dosageForm":"Tablet","sponsorNew":"Chia Tai Tianqing Pharmaceutical Group \/ Inapplicable","highestDevelopmentStatusID":"1","companyTruncated":"Chia Tai Tianqing Pharmaceutical Group \/ Inapplicable"},{"orgOrder":0,"company":"Chia Tai Tianqing Pharmaceutical Group","sponsor":"Inapplicable","pharmaFlowCategory":"DU","therapeuticArea":"Hematology","country":"CHINA","productType":"Undisclosed","year":"2025","type":"Inapplicable","leadProduct":"Undisclosed","moa":"Undisclosed","graph1":"Hematology","graph2":"Undisclosed","graph3":"Chia Tai Tianqing Pharmaceutical Group","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Hematology","amount2New":0,"dosageForm":"Tablet","sponsorNew":"Chia Tai Tianqing Pharmaceutical Group \/ Inapplicable","highestDevelopmentStatusID":"1","companyTruncated":"Chia Tai Tianqing Pharmaceutical Group \/ Inapplicable"},{"orgOrder":0,"company":"King Hussein Cancer Center","sponsor":"Hikma Pharmaceuticals","pharmaFlowCategory":"DU","therapeuticArea":"Hematology","country":"","productType":"Vitamins\/Minerals\/Inorganic Salts","year":"2020","type":"Inapplicable","leadProduct":"Ferric Carboxymaltose","moa":"Fe","graph1":"Hematology","graph2":"Undisclosed","graph3":"King Hussein Cancer Center","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Hematology","amount2New":0,"dosageForm":"Intravenous","sponsorNew":"King Hussein Cancer Center \/ Hikma Pharmaceuticals","highestDevelopmentStatusID":"1","companyTruncated":"King Hussein Cancer Center \/ Hikma Pharmaceuticals"},{"orgOrder":0,"company":"G1 Therapeutics, Inc","sponsor":"Bionical Emas","pharmaFlowCategory":"DU","therapeuticArea":"Hematology","country":"U.S.A","productType":"Other Small Molecule","year":"2020","type":"Inapplicable","leadProduct":"Trilaciclib","moa":"Cyclin-dependent kinase 4 | Cyclin-dependent kinase 6","graph1":"Hematology","graph2":"Undisclosed","graph3":"G1 Therapeutics, Inc","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Hematology","amount2New":0,"dosageForm":"Intravenous","sponsorNew":"G1 Therapeutics, Inc \/ Bionical Emas","highestDevelopmentStatusID":"1","companyTruncated":"G1 Therapeutics, Inc \/ Bionical Emas"},{"orgOrder":0,"company":"Lowell Therapeutics","sponsor":"AcelRx Pharmaceuticals","pharmaFlowCategory":"D","therapeuticArea":"Hematology","country":"U.S.A","productType":"Other Small Molecule","year":"2021","type":"Acquisition","leadProduct":"Nafamostat","moa":"enzyme inhibitors: proteolytic enzyme inhibitors","graph1":"Hematology","graph2":"Undisclosed","graph3":"Lowell Therapeutics","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Hematology","amount2New":0,"dosageForm":"Intravenous Infusion","sponsorNew":"Lowell Therapeutics \/ AcelRx Pharmaceuticals","highestDevelopmentStatusID":"1","companyTruncated":"Lowell Therapeutics \/ AcelRx Pharmaceuticals"},{"orgOrder":0,"company":"Superficial Siderosis Research Alliance Inc.","sponsor":"Inapplicable","pharmaFlowCategory":"DU","therapeuticArea":"Hematology","country":"","productType":"Dietary Supplement","year":"2021","type":"Inapplicable","leadProduct":"Inosine","moa":"Purine nucleoside phosphorylase; IAG-nucleoside hydrolase; Purine nucleoside phosphorylase DeoD-type","graph1":"Hematology","graph2":"Undisclosed","graph3":"Superficial Siderosis Research Alliance Inc.","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Hematology","amount2New":0,"dosageForm":"Oral Capsule","sponsorNew":"Superficial Siderosis Research Alliance Inc. \/ Inapplicable","highestDevelopmentStatusID":"1","companyTruncated":"Superficial Siderosis Research Alliance Inc. \/ Inapplicable"},{"orgOrder":0,"company":"Novartis Pharmaceuticals Corporation","sponsor":"Inapplicable","pharmaFlowCategory":"DU","therapeuticArea":"Hematology","country":"SWITZERLAND","productType":"Other Small Molecule","year":"2020","type":"Inapplicable","leadProduct":"Nilotinib","moa":"Tyrosine-protein kinase ABL","graph1":"Hematology","graph2":"Undisclosed","graph3":"Novartis Pharmaceuticals Corporation","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Hematology","amount2New":0,"dosageForm":"Oral","sponsorNew":"Novartis Pharmaceuticals Corporation \/ Inapplicable","highestDevelopmentStatusID":"1","companyTruncated":"Novartis Pharmaceuticals Corporation \/ Inapplicable"},{"orgOrder":0,"company":"Yunfeng Cheng","sponsor":"Shanghai Zhongshan Hospital | Shanghai Jinshan Hospital | Zhongshan Qingpu Hospital, Fudan University | Zhongshan Wusong Hospital, Fudan University | Macau University of Science and Technology Hospital | Health and Humanity Research Centre, Hongkong | Dr.","pharmaFlowCategory":"DU","therapeuticArea":"Hematology","country":"","productType":"Other Small Molecule","year":"2024","type":"Inapplicable","leadProduct":"Hydroxychloroquine Sulphate","moa":"Toll-like receptor 9","graph1":"Hematology","graph2":"Undisclosed","graph3":"Yunfeng Cheng","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Hematology","amount2New":0,"dosageForm":"Oral Tablet","sponsorNew":"Yunfeng Cheng \/ Shanghai Zhongshan Hospital | Shanghai Jinshan Hospital | Zhongshan Qingpu Hospital, Fudan University | Zhongshan Wusong Hospital, Fudan University | Macau University of Science and Technology Hospital | Health and Humanity Research Centre, Hongkong | Dr.","highestDevelopmentStatusID":"1","companyTruncated":"Yunfeng Cheng \/ Shanghai Zhongshan Hospital | Shanghai Jinshan Hospital | Zhongshan Qingpu Hospital, Fudan University | Zhongshan Wusong Hospital, Fudan University | Macau University of Science and Technology Hospital | Health and Humanity Research Centre, Hongkong | Dr."},{"orgOrder":0,"company":"Yunfeng Cheng","sponsor":"Shanghai Zhongshan Hospital | Shanghai Jinshan Hospital | Zhongshan Qingpu Hospital, Fudan University | Zhongshan Wusong Hospital, Fudan University | Macau University of Science and Technology Hospital | Health and Humanity Research Centre, Hongkong | Dr.","pharmaFlowCategory":"DU","therapeuticArea":"Hematology","country":"","productType":"Other Small Molecule","year":"2024","type":"Inapplicable","leadProduct":"Hydroxychloroquine Sulphate","moa":"Toll-like receptor 9","graph1":"Hematology","graph2":"Undisclosed","graph3":"Yunfeng Cheng","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Hematology","amount2New":0,"dosageForm":"Oral Tablet","sponsorNew":"Yunfeng Cheng \/ Shanghai Zhongshan Hospital | Shanghai Jinshan Hospital | Zhongshan Qingpu Hospital, Fudan University | Zhongshan Wusong Hospital, Fudan University | Macau University of Science and Technology Hospital | Health and Humanity Research Centre, Hongkong | Dr.","highestDevelopmentStatusID":"1","companyTruncated":"Yunfeng Cheng \/ Shanghai Zhongshan Hospital | Shanghai Jinshan Hospital | Zhongshan Qingpu Hospital, Fudan University | Zhongshan Wusong Hospital, Fudan University | Macau University of Science and Technology Hospital | Health and Humanity Research Centre, Hongkong | Dr."},{"orgOrder":0,"company":"Yunfeng Cheng","sponsor":"Shanghai Zhongshan Hospital | Shanghai Jinshan Hospital | Zhongshan Qingpu Hospital, Fudan University | Zhongshan Wusong Hospital, Fudan University | Macau University of Science and Technology Hospital | Health and Humanity Research Centre, Hongkong | Dr.","pharmaFlowCategory":"DU","therapeuticArea":"Hematology","country":"","productType":"Other Small Molecule","year":"2024","type":"Inapplicable","leadProduct":"Hydroxychloroquine Sulphate","moa":"Toll-like receptor 9","graph1":"Hematology","graph2":"Undisclosed","graph3":"Yunfeng Cheng","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Hematology","amount2New":0,"dosageForm":"Oral Tablet","sponsorNew":"Yunfeng Cheng \/ Shanghai Zhongshan Hospital | Shanghai Jinshan Hospital | Zhongshan Qingpu Hospital, Fudan University | Zhongshan Wusong Hospital, Fudan University | Macau University of Science and Technology Hospital | Health and Humanity Research Centre, Hongkong | Dr.","highestDevelopmentStatusID":"1","companyTruncated":"Yunfeng Cheng \/ Shanghai Zhongshan Hospital | Shanghai Jinshan Hospital | Zhongshan Qingpu Hospital, Fudan University | Zhongshan Wusong Hospital, Fudan University | Macau University of Science and Technology Hospital | Health and Humanity Research Centre, Hongkong | Dr."},{"orgOrder":0,"company":"ImmunityBio","sponsor":"Inapplicable","pharmaFlowCategory":"DU","therapeuticArea":"Hematology","country":"U.S.A","productType":"Undisclosed","year":"2025","type":"Inapplicable","leadProduct":"Nogapendekin-Alfa Inbakicept","moa":"Undisclosed","graph1":"Hematology","graph2":"Undisclosed","graph3":"ImmunityBio","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Hematology","amount2New":0,"dosageForm":"Subcutaneous Injection","sponsorNew":"ImmunityBio \/ Inapplicable","highestDevelopmentStatusID":"1","companyTruncated":"ImmunityBio \/ Inapplicable"},{"orgOrder":0,"company":"Lonza Biologics Inc","sponsor":"Anthos Therapeutics","pharmaFlowCategory":"D","therapeuticArea":"Hematology","country":"U.S.A","productType":"Antibody","year":"2020","type":"Partnership","leadProduct":"Abelacimab","moa":"Coagulation factor XI","graph1":"Hematology","graph2":"Undisclosed","graph3":"Lonza Biologics Inc","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Hematology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Lonza Biologics Inc \/ Anthos Therapeutics","highestDevelopmentStatusID":"1","companyTruncated":"Lonza Biologics Inc \/ Anthos Therapeutics"},{"orgOrder":0,"company":"Sidero Bioscience","sponsor":"SRS Life Sciences Pte ltd","pharmaFlowCategory":"D","therapeuticArea":"Hematology","country":"U.S.A","productType":"Cell and Gene therapy","year":"2020","type":"Agreement","leadProduct":"FTH1","moa":"Undisclosed","graph1":"Hematology","graph2":"Undisclosed","graph3":"Sidero Bioscience","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Hematology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Sidero Bioscience \/ SRS Life Sciences Pte ltd","highestDevelopmentStatusID":"1","companyTruncated":"Sidero Bioscience \/ SRS Life Sciences Pte ltd"},{"orgOrder":0,"company":"Shanghai Cell Therapy Group","sponsor":"Baize Plan Fund","pharmaFlowCategory":"D","therapeuticArea":"Hematology","country":"","productType":"Cell and Gene therapy","year":"2020","type":"Collaboration","leadProduct":"Hematopoietic Stem Cell","moa":"Undisclosed","graph1":"Hematology","graph2":"Undisclosed","graph3":"Shanghai Cell Therapy Group","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Hematology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Shanghai Cell Therapy Group \/ Baize Plan Fund","highestDevelopmentStatusID":"1","companyTruncated":"Shanghai Cell Therapy Group \/ Baize Plan Fund"},{"orgOrder":0,"company":"Sourse","sponsor":"Citruslabs","pharmaFlowCategory":"DU","therapeuticArea":"Hematology","country":"","productType":"Dietary Supplement","year":"2022","type":"Inapplicable","leadProduct":"Hype Bites Supplement","moa":"Undisclosed","graph1":"Hematology","graph2":"Undisclosed","graph3":"Sourse","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Hematology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Sourse \/ Citruslabs","highestDevelopmentStatusID":"1","companyTruncated":"Sourse \/ Citruslabs"},{"orgOrder":0,"company":"Lindenwood University","sponsor":"Increnovo, LLC","pharmaFlowCategory":"DU","therapeuticArea":"Hematology","country":"","productType":"Dietary Supplement","year":"2023","type":"Inapplicable","leadProduct":"Time To Exhaustion At Velocity At Vo2Max","moa":"Undisclosed","graph1":"Hematology","graph2":"Undisclosed","graph3":"Lindenwood University","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Hematology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Lindenwood University \/ Increnovo, LLC","highestDevelopmentStatusID":"1","companyTruncated":"Lindenwood University \/ Increnovo, LLC"},{"orgOrder":0,"company":"Hangzhou Agile Groups Network Technology Co., Ltd.","sponsor":"Inapplicable","pharmaFlowCategory":"DU","therapeuticArea":"Hematology","country":"","productType":"Dietary Supplement","year":"2023","type":"Inapplicable","leadProduct":"Minayo Yeast","moa":"Undisclosed","graph1":"Hematology","graph2":"Undisclosed","graph3":"Hangzhou Agile Groups Network Technology Co., Ltd.","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Hematology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Hangzhou Agile Groups Network Technology Co., Ltd. \/ Inapplicable","highestDevelopmentStatusID":"1","companyTruncated":"Hangzhou Agile Groups Network Technology Co., Ltd. \/ Inapplicable"},{"orgOrder":0,"company":"VarmX","sponsor":"Ysios Capital","pharmaFlowCategory":"D","therapeuticArea":"Hematology","country":"NETHERLANDS","productType":"Enzyme","year":"2020","type":"Series B Financing","leadProduct":"VMX-C001","moa":"Factor Xa","graph1":"Hematology","graph2":"Undisclosed","graph3":"VarmX","amount2":0.040000000000000001,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Hematology","amount2New":0.040000000000000001,"dosageForm":"Undisclosed","sponsorNew":"VarmX \/ Ysios Capital","highestDevelopmentStatusID":"1","companyTruncated":"VarmX \/ Ysios Capital"},{"orgOrder":0,"company":"Laboratori Derivati Organici","sponsor":"Cerus Dmcc","pharmaFlowCategory":"D","therapeuticArea":"Hematology","country":"ITALY","productType":"Other Large Molecule","year":"2020","type":"Acquisition","leadProduct":"Heparin Sodium","moa":"Antithrombin-III","graph1":"Hematology","graph2":"Undisclosed","graph3":"Laboratori Derivati Organici","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Hematology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Laboratori Derivati Organici \/ Cerus Dmcc","highestDevelopmentStatusID":"1","companyTruncated":"Laboratori Derivati Organici \/ Cerus Dmcc"},{"orgOrder":0,"company":"First Affiliated Hospital of Zhejiang University","sponsor":"Zhejiang University | Ningbo No.2 Hospital | Taizhou Hospital of Zhejiang Province | The Central Hospital of Lishui City | Taizhou Enze Hospital | Taizhou First People's Hospital | Boston Scientific","pharmaFlowCategory":"DU","therapeuticArea":"Hematology","country":"","productType":"Other Small Molecule","year":"2021","type":"Inapplicable","leadProduct":"Rivaroxaban","moa":"Coagulation factor X","graph1":"Hematology","graph2":"Undisclosed","graph3":"First Affiliated Hospital of Zhejiang University","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Hematology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"First Affiliated Hospital of Zhejiang University \/ Zhejiang University | Ningbo No.2 Hospital | Taizhou Hospital of Zhejiang Province | The Central Hospital of Lishui City | Taizhou Enze Hospital | Taizhou First People's Hospital | Boston Scientific","highestDevelopmentStatusID":"1","companyTruncated":"First Affiliated Hospital of Zhejiang University \/ Zhejiang University | Ningbo No.2 Hospital | Taizhou Hospital of Zhejiang Province | The Central Hospital of Lishui City | Taizhou Enze Hospital | Taizhou First People's Hospital | Boston Scientific"},{"orgOrder":0,"company":"PharmaLinea","sponsor":"Clinres Farmacija","pharmaFlowCategory":"DU","therapeuticArea":"Hematology","country":"","productType":"Vitamins\/Minerals\/Inorganic Salts","year":"2021","type":"Inapplicable","leadProduct":"Iron","moa":"Hemoglobin (HB)","graph1":"Hematology","graph2":"Undisclosed","graph3":"PharmaLinea","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Hematology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"PharmaLinea \/ Clinres Farmacija","highestDevelopmentStatusID":"1","companyTruncated":"PharmaLinea \/ Clinres Farmacija"},{"orgOrder":0,"company":"IBSA Institut Biochimique","sponsor":"Informapro Srl","pharmaFlowCategory":"DU","therapeuticArea":"Hematology","country":"SWITZERLAND","productType":"Other Small Molecule","year":"2023","type":"Inapplicable","leadProduct":"Ferric Pyrophosphate Citrate","moa":"Ferritin light chain; Hemoglobin subunit alpha; Hemoglobin subunit beta","graph1":"Hematology","graph2":"Undisclosed","graph3":"IBSA Institut Biochimique","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Hematology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"IBSA Institut Biochimique \/ Informapro Srl","highestDevelopmentStatusID":"1","companyTruncated":"IBSA Institut Biochimique \/ Informapro Srl"},{"orgOrder":0,"company":"Dr. Anil K. Gupta Medicine Professional Corporation","sponsor":"Inapplicable","pharmaFlowCategory":"DU","therapeuticArea":"Hematology","country":"","productType":"Vitamins\/Minerals\/Inorganic Salts","year":"2024","type":"Inapplicable","leadProduct":"Ferrous Fumarate","moa":"Transferrin receptor protein 1; Egl nine homolog 1; Histone deacetylase 8; Alpha-hemoglobin-stabilizing protein; Hemoglobin subunit alpha; Frataxin, mitochondrial; Ferritin heavy chain; Flap endonuclease 1; Endonuclease 8-like 1; Endonuclease 8-like 2; DNA polymerase beta; Ceruloplasmin; Serotransferrin","graph1":"Hematology","graph2":"Undisclosed","graph3":"Dr. Anil K. Gupta Medicine Professional Corporation","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Hematology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Dr. Anil K. Gupta Medicine Professional Corporation \/ Inapplicable","highestDevelopmentStatusID":"1","companyTruncated":"Dr. Anil K. Gupta Medicine Professional Corporation \/ Inapplicable"},{"orgOrder":0,"company":"Hangzhou Agile Groups Network Technology Co., Ltd.","sponsor":"Inapplicable","pharmaFlowCategory":"DU","therapeuticArea":"Hematology","country":"","productType":"Vitamins\/Minerals\/Inorganic Salts","year":"2025","type":"Inapplicable","leadProduct":"Iron","moa":"Hemoglobin (HB)","graph1":"Hematology","graph2":"Undisclosed","graph3":"Hangzhou Agile Groups Network Technology Co., Ltd.","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Hematology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Hangzhou Agile Groups Network Technology Co., Ltd. \/ Inapplicable","highestDevelopmentStatusID":"1","companyTruncated":"Hangzhou Agile Groups Network Technology Co., Ltd. \/ Inapplicable"},{"orgOrder":0,"company":"Meitheal Pharmaceuticals","sponsor":"Premier","pharmaFlowCategory":"DU","therapeuticArea":"Hematology","country":"U.S.A","productType":"Other Small Molecule","year":"2021","type":"Inapplicable","leadProduct":"Enoxaparin Sodium","moa":"Antithrombin-III","graph1":"Hematology","graph2":"Undisclosed","graph3":"Meitheal Pharmaceuticals","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Hematology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Meitheal Pharmaceuticals \/ Premier","highestDevelopmentStatusID":"1","companyTruncated":"Meitheal Pharmaceuticals \/ Premier"},{"orgOrder":0,"company":"Hamad Medical Corporation","sponsor":"Inapplicable","pharmaFlowCategory":"DU","therapeuticArea":"Hematology","country":"","productType":"Protein","year":"2021","type":"Inapplicable","leadProduct":"Human Plasma Protein Fraction","moa":"Undisclosed","graph1":"Hematology","graph2":"Undisclosed","graph3":"Hamad Medical Corporation","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Hematology","amount2New":0,"dosageForm":"Infusion","sponsorNew":"Hamad Medical Corporation \/ Inapplicable","highestDevelopmentStatusID":"1","companyTruncated":"Hamad Medical Corporation \/ Inapplicable"},{"orgOrder":0,"company":"Egymedicalpedia","sponsor":"Al-Azhar University","pharmaFlowCategory":"DU","therapeuticArea":"Hematology","country":"","productType":"Protein","year":"2024","type":"Inapplicable","leadProduct":"Lactoferrin","moa":"Tryptase alpha\/beta-1 (Tryptase)","graph1":"Hematology","graph2":"Undisclosed","graph3":"Egymedicalpedia","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Hematology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Egymedicalpedia \/ Al-Azhar University","highestDevelopmentStatusID":"1","companyTruncated":"Egymedicalpedia \/ Al-Azhar University"},{"orgOrder":0,"company":"University of Westminster","sponsor":"Gencor Pacific Group","pharmaFlowCategory":"DU","therapeuticArea":"Hematology","country":"","productType":"Other Small Molecule","year":"2020","type":"Inapplicable","leadProduct":"Ferrous Sulfate","moa":"Undisclosed","graph1":"Hematology","graph2":"Undisclosed","graph3":"University of Westminster","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Hematology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"University of Westminster \/ Gencor Pacific Group","highestDevelopmentStatusID":"1","companyTruncated":"University of Westminster \/ Gencor Pacific Group"},{"orgOrder":0,"company":"Cellphire Therapeutics","sponsor":"Inapplicable","pharmaFlowCategory":"DU","therapeuticArea":"Hematology","country":"U.S.A","productType":"Undisclosed","year":"2020","type":"Inapplicable","leadProduct":"Thrombosomes","moa":"Platelet level","graph1":"Hematology","graph2":"Undisclosed","graph3":"Cellphire Therapeutics","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Hematology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Cellphire Therapeutics \/ Inapplicable","highestDevelopmentStatusID":"1","companyTruncated":"Cellphire Therapeutics \/ Inapplicable"},{"orgOrder":0,"company":"Shanghai BDgene Co., Ltd.","sponsor":"923rd Hospital of Joint Logistics Support Force of PLA","pharmaFlowCategory":"DU","therapeuticArea":"Hematology","country":"","productType":"Undisclosed","year":"2021","type":"Inapplicable","leadProduct":"BD211","moa":"Undisclosed","graph1":"Hematology","graph2":"Undisclosed","graph3":"Shanghai BDgene Co., Ltd.","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Hematology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Shanghai BDgene Co., Ltd. \/ 923rd Hospital of Joint Logistics Support Force of PLA","highestDevelopmentStatusID":"1","companyTruncated":"Shanghai BDgene Co., Ltd. \/ 923rd Hospital of Joint Logistics Support Force of PLA"},{"orgOrder":0,"company":"Applied Science & Performance Institute","sponsor":"Inapplicable","pharmaFlowCategory":"DU","therapeuticArea":"Hematology","country":"","productType":"Undisclosed","year":"2022","type":"Inapplicable","leadProduct":"Iron Supplement","moa":"Undisclosed","graph1":"Hematology","graph2":"Undisclosed","graph3":"Applied Science & Performance Institute","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Hematology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Applied Science & Performance Institute \/ Inapplicable","highestDevelopmentStatusID":"1","companyTruncated":"Applied Science & Performance Institute \/ Inapplicable"},{"orgOrder":0,"company":"GATT Technologies BV","sponsor":"Syneos Health","pharmaFlowCategory":"DU","therapeuticArea":"Hematology","country":"","productType":"Undisclosed","year":"2022","type":"Inapplicable","leadProduct":"GATT-Patch","moa":"Undisclosed","graph1":"Hematology","graph2":"Undisclosed","graph3":"GATT Technologies BV","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Hematology","amount2New":0,"dosageForm":"Patch","sponsorNew":"GATT Technologies BV \/ Syneos Health","highestDevelopmentStatusID":"1","companyTruncated":"GATT Technologies BV \/ Syneos Health"},{"orgOrder":0,"company":"NovoBliss Research","sponsor":"Orgenetics, Inc.","pharmaFlowCategory":"DU","therapeuticArea":"Hematology","country":"","productType":"Undisclosed","year":"2023","type":"Inapplicable","leadProduct":"Iron Exctract","moa":"Undisclosed","graph1":"Hematology","graph2":"Undisclosed","graph3":"NovoBliss Research","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Hematology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"NovoBliss Research \/ Orgenetics, Inc.","highestDevelopmentStatusID":"1","companyTruncated":"NovoBliss Research \/ Orgenetics, Inc."},{"orgOrder":0,"company":"University of Ulster","sponsor":"Solvotrin Therapeutics - Active Iron | National Health Service, UK","pharmaFlowCategory":"DU","therapeuticArea":"Hematology","country":"","productType":"Undisclosed","year":"2024","type":"Inapplicable","leadProduct":"Adipreg","moa":"Undisclosed","graph1":"Hematology","graph2":"Undisclosed","graph3":"University of Ulster","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Hematology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"University of Ulster \/ Solvotrin Therapeutics - Active Iron | National Health Service, UK","highestDevelopmentStatusID":"1","companyTruncated":"University of Ulster \/ Solvotrin Therapeutics - Active Iron | National Health Service, UK"},{"orgOrder":0,"company":"Akram Medical Complex","sponsor":"Scotmann Pharmaceuticals | The Searle Company Limited Pakistan","pharmaFlowCategory":"DU","therapeuticArea":"Hematology","country":"","productType":"Undisclosed","year":"2024","type":"Inapplicable","leadProduct":"Iron III Hydroxide Polymaltose Complex","moa":"Undisclosed","graph1":"Hematology","graph2":"Undisclosed","graph3":"Akram Medical Complex","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Hematology","amount2New":0,"dosageForm":"Tablet","sponsorNew":"Akram Medical Complex \/ Scotmann Pharmaceuticals | The Searle Company Limited Pakistan","highestDevelopmentStatusID":"1","companyTruncated":"Akram Medical Complex \/ Scotmann Pharmaceuticals | The Searle Company Limited Pakistan"},{"orgOrder":0,"company":"PharmaLinea","sponsor":"Inapplicable","pharmaFlowCategory":"DU","therapeuticArea":"Hematology","country":"","productType":"Vitamins\/Minerals\/Inorganic Salts","year":"2022","type":"Inapplicable","leadProduct":"Ferrous Sulfate","moa":"Iron stores","graph1":"Hematology","graph2":"Undisclosed","graph3":"PharmaLinea","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Hematology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"PharmaLinea \/ Inapplicable","highestDevelopmentStatusID":"1","companyTruncated":"PharmaLinea \/ Inapplicable"},{"orgOrder":0,"company":"IBSA Institut Biochimique","sponsor":"Informapro Srl","pharmaFlowCategory":"DU","therapeuticArea":"Hematology","country":"SWITZERLAND","productType":"Vitamins\/Minerals\/Inorganic Salts","year":"2022","type":"Inapplicable","leadProduct":"Ibsa Iron Odf","moa":"Undisclosed","graph1":"Hematology","graph2":"Undisclosed","graph3":"IBSA Institut Biochimique","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Hematology","amount2New":0,"dosageForm":"Film, Dispersible","sponsorNew":"IBSA Institut Biochimique \/ Informapro Srl","highestDevelopmentStatusID":"1","companyTruncated":"IBSA Institut Biochimique \/ Informapro Srl"},{"orgOrder":0,"company":"Fundaci\u00f3 Eurecat","sponsor":"Laboratorio Echevarne | Health Tech Bio Actives, S.L.U.","pharmaFlowCategory":"DU","therapeuticArea":"Hematology","country":"","productType":"Vitamins\/Minerals\/Inorganic Salts","year":"2023","type":"Inapplicable","leadProduct":"Methylcobalamin","moa":"Methionine synthase","graph1":"Hematology","graph2":"Undisclosed","graph3":"Fundaci\u00f3 Eurecat","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Hematology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Fundaci\u00f3 Eurecat \/ Laboratorio Echevarne | Health Tech Bio Actives, S.L.U.","highestDevelopmentStatusID":"1","companyTruncated":"Fundaci\u00f3 Eurecat \/ Laboratorio Echevarne | Health Tech Bio Actives, S.L.U."},{"orgOrder":0,"company":"S.LAB (SOLOWAYS)","sponsor":"Triangel Scientific | Center of New Medical Technologies","pharmaFlowCategory":"DU","therapeuticArea":"Hematology","country":"","productType":"Vitamins\/Minerals\/Inorganic Salts","year":"2023","type":"Inapplicable","leadProduct":"Nicotinamide","moa":"Undisclosed","graph1":"Hematology","graph2":"Undisclosed","graph3":"S.LAB (SOLOWAYS)","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Hematology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"S.LAB (SOLOWAYS) \/ Triangel Scientific | Center of New Medical Technologies","highestDevelopmentStatusID":"1","companyTruncated":"S.LAB (SOLOWAYS) \/ Triangel Scientific | Center of New Medical Technologies"},{"orgOrder":0,"company":"University of Calgary","sponsor":"Mitacs | Natural Sciences and Engineering Research Council, Canada","pharmaFlowCategory":"DU","therapeuticArea":"Hematology","country":"","productType":"Vitamins\/Minerals\/Inorganic Salts","year":"2025","type":"Inapplicable","leadProduct":"Ferrous Sulfate","moa":"Iron stores","graph1":"Hematology","graph2":"Undisclosed","graph3":"University of Calgary","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Hematology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"University of Calgary \/ Mitacs | Natural Sciences and Engineering Research Council, Canada","highestDevelopmentStatusID":"1","companyTruncated":"University of Calgary \/ Mitacs | Natural Sciences and Engineering Research Council, Canada"},{"orgOrder":0,"company":"University of Westminster","sponsor":"Pharmako Biotechnologies Pty Ltd","pharmaFlowCategory":"DU","therapeuticArea":"Hematology","country":"","productType":"Dietary Supplement","year":"2025","type":"Inapplicable","leadProduct":"HydroCurc","moa":"Undisclosed","graph1":"Hematology","graph2":"Undisclosed","graph3":"University of Westminster","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Hematology","amount2New":0,"dosageForm":"Capsule","sponsorNew":"University of Westminster \/ Pharmako Biotechnologies Pty Ltd","highestDevelopmentStatusID":"1","companyTruncated":"University of Westminster \/ Pharmako Biotechnologies Pty Ltd"}]
Find Clinical Drug Development Pipelines & Deals | PipelineProspector
Details :
HydroCurc is a Dietary Supplement drug candidate, which is currently being evaluated in clinical studies for the treatment of Iron Deficiencies.
Sponsor :
Shanghai Zhongshan Hospital | Shanghai Jinshan Hospital | Zhongshan Qingpu Hospital, Fudan University | Zhongshan Wusong Hospital, Fudan University | Macau University of Science and Technology Hospital | Health and Humanity Research Centre, Hongkong | Dr.
Sponsor :
Shanghai Zhongshan Hospital | Shanghai Jinshan Hospital | Zhongshan Qingpu Hospital, Fudan University | Zhongshan Wusong Hospital, Fudan University | Macau University of Science and Technology Hospital | Health and Humanity Research Centre, Hongkong | Dr.
Sponsor :
Shanghai Zhongshan Hospital | Shanghai Jinshan Hospital | Zhongshan Qingpu Hospital, Fudan University | Zhongshan Wusong Hospital, Fudan University | Macau University of Science and Technology Hospital | Health and Humanity Research Centre, Hongkong | Dr.
Sponsor :
Shanghai Zhongshan Hospital | Shanghai Jinshan Hospital | Zhongshan Qingpu Hospital, Fudan University | Zhongshan Wusong Hospital, Fudan University | Macau University of Science and Technology Hospital | Health and Humanity Research Centre, Hongkong | Dr.
Reset All
